News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
R. Taylor Sundby: It was a huge privilege to speak to Congress today alongside Children’s Tumor Foundation
Photo taken from R. Taylor Sundby/LinkedIn
Jan 18, 2024, 09:13

R. Taylor Sundby: It was a huge privilege to speak to Congress today alongside Children’s Tumor Foundation

R. Taylor Sundby, Pediatric Hematologist-Oncologist at the National Cancer Institute, posted on LinkedIn:

“It was a huge privilege to speak to Congress today alongside Children’s Tumor Foundation, advocates, patients and caregivers about the impact and importance of continued funding for our quest to End NF.

The neurofibromatosis community is inspiring and so welcoming! Thank you Littlest Tumor for hosting and Rep Gallagher, Rep Pokan and Senator Baldwin for sponsoring!”

No alternative text description for this image

Source: R. Taylor Sundby/LinkedIn

cancer Children's Tumor Foundation Neurofibromatosis OncoDaily Oncology R. Taylor Sundby Rep Gallagher Rep Pokan Senator Baldwin
Special Coverage
Insight
Jan 16, 2025, 09:37
Laura Bukavina: Age doesn't limit EV efficacy
Blog
Jan 16, 2025, 09:28
Glenn J. Hanna: Multidisciplinary approach to treat HPV-driven oropharyngeal cancer
Societies
Jan 16, 2025, 09:23
A look back on 2024 MCI Precision Oncology - Miami Cancer Institute Research
Societies
Jan 16, 2025, 09:17
MD Anderson has received a $10 million gift to support Be Well Beaumont initiative
Science
Jan 16, 2025, 09:12
Erman Akkus: TACE plus+ treatments in Hepato-Cellular Carcinoma
Dialogues
Jan 16, 2025, 09:08
Hope, Research, and Advocacy: Paving the Way to a Cure
Insight
Jan 16, 2025, 08:54
Financial Toxicity in Oncology: Impact and Proposed Solutions in JCO Oncology Practice
Insight
Jan 16, 2025, 08:49
EORTC meta-analysis: Progression-free survival as surrogate in advanced cervical carcinoma
Insight
Jan 16, 2025, 08:42
Hidehito Horinouchi: Telisotuzumab Vedotin and Osimertinib in EGFR-Mutated NSCLC
Career
Jan 16, 2025, 08:14
Narjust Florez was named as a health equity champion by Boston Business Journal
Blog
Jan 16, 2025, 07:14
Remembering Amy Babler: A fearless Advocate for Cancer Awareness and Communications
Insight
Jan 16, 2025, 07:08
Predictive Oncology has Announced Agreement to be Acquired by Renovaro